An invalid vocabulary is selected. Please change it in the options.
Title Creditssort descending Start date - Expiration date
NCCN Pharmacy Updates: Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas 1.00 06/08/2020 - 12:00am to 02/07/2021 - 12:00am
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 1.00 04/10/2020 - 12:00am to 04/10/2021 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer 1.00 03/18/2020 - 12:00am to 03/18/2021 - 12:00am
Evolution of Immunotherapy and Management of Complex Toxicities 1.00 05/20/2020 - 12:00am to 03/01/2021 - 12:00am
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Rectal Cancer 1.00 03/02/2020 - 12:00am to 08/02/2020 - 12:00am
Talking to Patients about Cancer Treatment, Risk Factors, and Treatment Cessation during the COVID-19 Pandemic 1.00 04/20/2020 - 12:00am to 04/20/2021 - 12:00am
Survivorship Needs of Patients Living with Chronic Metastatic Disease 1.00 05/21/2020 - 12:00am to 03/01/2021 - 12:00am
NCCN Pharmacy Updates: New Targets and Treatment Options for Acute Myeloid Leukemia 1.00 12/06/2019 - 12:00am to 07/12/2020 - 12:00am
NCCN Pharmacy Updates: Emerging Strategies in the Treatment of Venous Thromboembolism 1.00 06/08/2020 - 12:00am to 03/07/2021 - 12:00am
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of HER-2 Positive Breast Cancer 1.04 10/18/2019 - 12:00am to 10/18/2020 - 12:00am
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: New Treatments for Metastatic Lung Cancer 1.08 12/23/2019 - 12:00am to 12/23/2020 - 12:00am
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Managing Cancer Pain in the U.S. Opioid Crisis 1.25 12/16/2019 - 12:00am to 12/16/2020 - 12:00am
Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers 1.25 05/15/2020 - 12:00am to 03/01/2021 - 12:00am
Role of Biosimilars in the Oncology Ecosystem 1.25 05/15/2020 - 12:00am to 03/01/2021 - 12:00am
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of Follicular Lymphoma and Diffuse... 1.25 11/05/2019 - 12:00am to 11/05/2020 - 12:00am

Pages